US Stock MarketDetailed Quotes
SILO Silo Pharma
- 0.895
- -0.015-1.66%
Trading Nov 22 12:00 ET
4.01MMarket Cap-771P/E (TTM)
0.930High0.890Low50.39KVolume0.910Open0.910Pre Close45.84KTurnover1.24%Turnover RatioLossP/E (Static)4.48MShares4.50052wk High0.59P/B3.64MFloat Cap0.84152wk Low--Dividend TTM4.07MShs Float19.500Historical High--Div YieldTTM4.39%Amplitude0.841Historical Low0.909Avg Price1Lot Size
About Silo Pharma Company
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.
Company Profile
SymbolSILO
Company NameSilo Pharma
Listing DateSep 27, 2022
Founded2010
CEOMr. Eric Weisblum
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address677 North Washington Boulevard
CitySarasota
ProvinceFlorida
CountryUnited States of America
Zip Code34236
Phone1-718-400-9031
Websitehttp://www.silopharma.com
Company Executives
- Name
- Position
- Salary
- Eric Weisblum
- Chairman of the Board, Chief Executive Officer and President
- 569.01K
- Daniel E. Ryweck
- Chief Financial Officer and Principal Accounting Officer
- 62.69K
- Dr. Kevin Munoz
- Independent Director
- 25.00K
- Dr. Jeff Pavell, M.D.
- Independent Director
- 25.00K
- Wayne D. Linsley
- Independent Director
- 45.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data